Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study.

Holtz TH, Kabera G, Mthiyane T, Zingoni T, Nadesan S, Ross D, Allen J, Chideya S, Sunpath H, Rustomjee R.

Lancet Infect Dis. 2011 Jul;11(7):533-40. doi: 10.1016/S1473-3099(11)70057-3. Epub 2011 Apr 20.

PMID:
21514234
2.

Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy.

Abimbola TO, Marston BJ, Date AA, Blandford JM, Sangrujee N, Wiktor SZ.

J Acquir Immune Defic Syndr. 2012 May 1;60(1):e1-7. doi: 10.1097/QAI.0b013e318246538f.

PMID:
22240465
3.

Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.

Hanrahan CF, Selibas K, Deery CB, Dansey H, Clouse K, Bassett J, Scott L, Stevens W, Sanne I, Van Rie A.

PLoS One. 2013 Jun 6;8(6):e65421. doi: 10.1371/journal.pone.0065421. Print 2013.

4.
5.

Evaluation of the World Health Organization algorithm for the diagnosis of HIV-associated sputum smear-negative tuberculosis.

Wilson D, Mbhele L, Badri M, Morroni C, Nachega J, Chaisson RE, Maartens G.

Int J Tuberc Lung Dis. 2011 Jul;15(7):919-24. doi: 10.5588/ijtld.10.0440.

PMID:
21682965
6.

Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment.

Banda H, Kang'ombe C, Harries AD, Nyangulu DS, Whitty CJ, Wirima JJ, Salaniponi FM, Maher D, Nunn P.

Int J Tuberc Lung Dis. 2000 Oct;4(10):968-74.

PMID:
11055765
7.

Impact of previous ART and of ART initiation on outcome of HIV-associated tuberculosis.

Girardi E, Palmieri F, Angeletti C, Vanacore P, Matteelli A, Gori A, Carbonara S, Ippolito G.

Clin Dev Immunol. 2012;2012:931325. doi: 10.1155/2012/931325. Epub 2012 Mar 22.

8.

Mortality associated with tuberculosis/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa.

Mabunda TE, Ramalivhana NJ, Dambisya YM.

Afr Health Sci. 2014 Dec;14(4):849-54. doi: 10.4314/ahs.v14i4.12.

9.

HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study.

Varma JK, Nateniyom S, Akksilp S, Mankatittham W, Sirinak C, Sattayawuthipong W, Burapat C, Kittikraisak W, Monkongdee P, Cain KP, Wells CD, Tappero JW.

BMC Infect Dis. 2009 Apr 13;9:42. doi: 10.1186/1471-2334-9-42.

10.

Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality.

Nunn P, Brindle R, Carpenter L, Odhiambo J, Wasunna K, Newnham R, Githui W, Gathua S, Omwega M, McAdam K.

Am Rev Respir Dis. 1992 Oct;146(4):849-54.

PMID:
1416409
11.

Survival of smear-positive multidrug resistant tuberculosis patients in Witbank, South Africa: A retrospective cohort study.

Olaleye AO, Beke AK.

Infect Dis (Lond). 2016;48(6):422-7. doi: 10.3109/23744235.2016.1153806. Epub 2016 Mar 8.

PMID:
26954520
12.

Performance of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings: a multisite study in Uganda.

Alamo ST, Kunutsor S, Walley J, Thoulass J, Evans M, Muchuro S, Matovu A, Katabira E.

Trop Med Int Health. 2012 Jul;17(7):884-95. doi: 10.1111/j.1365-3156.2012.03003.x. Epub 2012 May 11.

13.
14.

Evaluation of a diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV-infected adults.

Saranchuk P, Boulle A, Hilderbrand K, Coetzee D, Bedelu M, van Cutsem G, Meintjes G.

S Afr Med J. 2007 Jul;97(7):517-23.

15.

Reducing mortality from HIV infection and tuberculosis.

Koole O, Colebunders R.

Lancet Infect Dis. 2011 Jul;11(7):494-5. doi: 10.1016/S1473-3099(11)70094-9. Epub 2011 Apr 20. No abstract available.

PMID:
21514235
16.

Diagnosis and treatment of pulmonary tuberculosis in patients with HIV.

Mendelson M, van der Plas H, Maartens G.

Lancet Infect Dis. 2012 Apr;12(4):267-8; author reply 268-9. doi: 10.1016/S1473-3099(11)70373-5. No abstract available.

PMID:
22459081
17.

Diagnosis and treatment of pulmonary tuberculosis in patients with HIV.

Pandey DK, Roy G, Kumar S G, Saurabh S, Agarwal DK.

Lancet Infect Dis. 2012 Apr;12(4):267; author reply 268-9. doi: 10.1016/S1473-3099(11)70371-1. No abstract available.

PMID:
22459080
18.

Inaccuracy of death certificate diagnosis of tuberculosis and potential underdiagnosis of TB in a region of high HIV prevalence.

Liu TT, Wilson D, Dawood H, Cameron DW, Alvarez GG.

Clin Dev Immunol. 2012;2012:937013. doi: 10.1155/2012/937013. Epub 2012 Mar 19.

19.

Mortality among tuberculosis patients in the Democratic Republic of Congo.

Henegar C, Behets F, Vanden Driessche K, Tabala M, Bahati E, Bola V, Van Rie A.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1199-204. doi: 10.5588/ijtld.11.0613.

PMID:
22871326
20.

Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial.

Mwinga A, Nunn A, Ngwira B, Chintu C, Warndorff D, Fine P, Darbyshire J, Zumla A; LUSKAR collaboration.

Lancet. 2002 Oct 5;360(9339):1050-5.

PMID:
12383985

Supplemental Content

Support Center